NASDAQ:SHC

Sotera Health Company Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy SHC

*Your capital is at risk

$15.74

-0.0800 (-0.506%)

At Close: Jun 22, 2026

Sotera Health Company Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -99.53. In total, the insiders bought 2.68M and sold 144.48M SHC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-99.53
● Buy	2.68M shares
● Sell	144.48M shares
61% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence May 26, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -99.53. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 02, 2026 Buy	Common Stock M-Exempt	Rutz Michael P President Of Sterigenics	CEO / President	14 573 Value: $231.9K
Mar 02, 2026 Buy	Common Stock A-Award	Rutz Michael P President Of Sterigenics	CEO / President	45 223 Value: $719.5K
Mar 02, 2026 Sell	Common Stock F-InKind	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	8 240 Value: $131.1K
Mar 02, 2026 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	6 046 Value: $96.2K
Mar 02, 2026 Buy	Share Appreciation Units M-Exempt	Petras Michael B. Jr. Chairman & CEO	CEO / President	89 686 Value: $1.43M
Mar 02, 2026 Buy	Share Appreciation Units A-Award	Petras Michael B. Jr. Chairman & CEO	CEO / President	120 124 Value: $1.91M
Mar 02, 2026 Sell	Common Stock F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	79 104 Value: $1.26M
Mar 02, 2026 Sell	Common Stock F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	40 302 Value: $641.2K
Mar 02, 2026 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	31 339 Value: $498.6K
Mar 02, 2026 Sell	Common Stock F-InKind	Petras Michael B. Jr. Chairman & CEO	CEO / President	39 552 Value: $629.3K
Mar 02, 2026 Buy	Common Stock M-Exempt	Petras Michael B. Jr. Chairman & CEO	CEO / President	89 686 Value: $1.43M
Mar 02, 2026 Buy	Common Stock A-Award	Petras Michael B. Jr. Chairman & CEO	CEO / President	240 248 Value: $3.82M
Mar 02, 2026 Buy	Common Stock M-Exempt	Dimitrief Alexander SVP, General Counsel And Sec.	Officer	16 816 Value: $267.5K
Mar 02, 2026 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Dimitrief Alexander SVP, General Counsel And Sec.	Officer	7 941 Value: $126.3K
Mar 02, 2026 Sell	Common Stock F-InKind	Dimitrief Alexander SVP, General Counsel And Sec.	Officer	23 619 Value: $375.8K
Mar 02, 2026 Buy	Performance RSUs M-Exempt	Dimitrief Alexander SVP, General Counsel And Sec.	Officer	16 816 Value: $267.5K
Mar 02, 2026 Buy	Common Stock A-Award	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	59 355 Value: $944.3K
Mar 02, 2026 Buy	Performance RSUs M-Exempt	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	17 937 Value: $285.4K
Mar 02, 2026 Sell	Common Stock, $0.01 par value per share ("Common Stock") F-InKind	Rutz Michael P President Of Sterigenics	CEO / President	3 729 Value: $59.3K
Mar 02, 2026 Sell	Common Stock F-InKind	Rutz Michael P President Of Sterigenics	CEO / President	17 497 Value: $278.4K
Mar 02, 2026 Buy	Common Stock M-Exempt	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	17 937 Value: $285.4K
Mar 02, 2026 Sell	Common Stock F-InKind	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	23 988 Value: $381.6K
Mar 02, 2026 Buy	Performance RSUs A-Award	Lyons Jonathan M. Sr. Vice President, CFO	CEO / President	29 678 Value: $472.2K
Mar 02, 2026 Buy	Performance RSUs A-Award	Rutz Michael P President Of Sterigenics	CEO / President	22 612 Value: $359.8K
Mar 02, 2026 Buy	Performance RSUs M-Exempt	Rutz Michael P President Of Sterigenics	CEO / President	14 573 Value: $231.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SOTERA HEALTH COMPANY

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricul...

Read Full Profile Here